Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Consolidation Chemotherapy in Inoperable Stage III NSCLC
NCT00326378Phase 3Completed
- Sponsor
- Samsung Medical Center
- Start
- Oct 2005
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel, cisplatin in non-small cell lung cancer (NSCLC), sponsored by Samsung Medical Center. Started Oct 2005; status: completed.
02
Drugs
docetaxelcisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00326378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00326378.